Literature DB >> 25930182

[Functional disorders in the chronological progression of glaucoma].

Carl Erb1.   

Abstract

BACKGROUND: Glaucomatous optic neuropathy is a complex process, which not only leads to destruction of the retinal ganglion cells but also negatively influences the third and fourth neurons. Therefore, in histological studies of glaucoma a significant cell loss in both the lateral geniculate nucleus and in the visual cortex could be detected.
OBJECTIVE: The involvement of the entire visual pathway in glaucoma leads to a variety of functional disturbances, which are presented in this overview.
RESULTS: Besides the well-known visual field defects in glaucomatous optic neuropathy, additional disturbances occur in contrast sensitivity, color vision, stereo vision and increased sensitivity to glare. As a result, faces are less easily recognized , the reading speed is reduced, the location of objects is more complicated and the reaction rate decreases. All these alterations are increased with the progression of glaucomatous damage. DISCUSSION: The consequences of these visual impairments lead to an increasing social isolation and to an increased risk of falls and driving accidents, thereby significantly reducing the quality of life of glaucoma patients. Therefore, increasing awareness of these visual difficulties is necessary in the special care of patients with glaucoma and the domestic environment should be transformed accordingly.

Entities:  

Mesh:

Year:  2015        PMID: 25930182     DOI: 10.1007/s00347-015-0005-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  84 in total

Review 1.  Acquired colour vision defects in glaucoma-their detection and clinical significance.

Authors:  M Pacheco-Cutillas; D F Edgar; A Sahraie
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

2.  Psychophysical investigation of ganglion cell loss in early glaucoma.

Authors:  Paul G D Spry; Chris A Johnson; Steven L Mansberger; George A Cioffi
Journal:  J Glaucoma       Date:  2005-02       Impact factor: 2.503

3.  Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons.

Authors:  L A Kerrigan-Baumrind; H A Quigley; M E Pease; D F Kerrigan; R S Mitchell
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-03       Impact factor: 4.799

Review 4.  [Ocular blood flow regulation in glaucoma - examination with the ocular pressure flow analyzer (OPFA)].

Authors:  W-D Ulrich; A Moeller; C Ulrich; G Siebert; K-D Wernecke; C Erb
Journal:  Klin Monbl Augenheilkd       Date:  2015-02-20       Impact factor: 0.700

Review 5.  Diagnosis of glaucoma and detection of glaucoma progression using spectral domain optical coherence tomography.

Authors:  Dilraj S Grewal; Angelo P Tanna
Journal:  Curr Opin Ophthalmol       Date:  2013-03       Impact factor: 3.761

6.  Difficulty with out-loud and silent reading in glaucoma.

Authors:  Pradeep Y Ramulu; Bonnielin K Swenor; Joan L Jefferys; David S Friedman; Gary S Rubin
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-23       Impact factor: 4.799

7.  Detection of optic neuropathy in glaucomatous eyes with normal standard visual fields using a test battery of short-wavelength automated perimetry and pattern electroretinography.

Authors:  Andreas U Bayer; Klaus-Peter Maag; Carl Erb
Journal:  Ophthalmology       Date:  2002-07       Impact factor: 12.079

Review 8.  Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma.

Authors:  Yeni H Yücel; Qiang Zhang; Robert N Weinreb; Paul L Kaufman; Neeru Gupta
Journal:  Prog Retin Eye Res       Date:  2003-07       Impact factor: 21.198

Review 9.  [Risk factors in the results of the colour vision test Roth 28-hue (E) desaturated in glaucoma patients].

Authors:  C M Jass; D Böhringer; C Erb; J F Jordan
Journal:  Klin Monbl Augenheilkd       Date:  2013-07-10       Impact factor: 0.700

10.  Practical landmarks for visual field disability in glaucoma.

Authors:  Luke J Saunders; Richard A Russell; David P Crabb
Journal:  Br J Ophthalmol       Date:  2012-07-14       Impact factor: 4.638

View more
  1 in total

Review 1.  [Rho kinase inhibitors as new local therapy option in primary open angle glaucoma].

Authors:  C Erb; K Konieczka
Journal:  Ophthalmologe       Date:  2021-01-05       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.